All
Opdivo Making Strides in Advanced Bladder Cancer
July 7th 2016“Urothelial cancer is a common type of bladder cancer where patients experience high rates of recurrence and remains an area where new treatment approaches are needed, further underscoring the importance of this designation for Opdivo,” said Jean Viallet.
Genetic Counselors Are Essential in Genetic Testing for Lynch Syndrome
July 6th 2016There are about one million people in the United States with Lynch syndrome and yet, it is estimated that only 5 percent of this particular population is aware of the fact they hold one of the five Lynch syndrome genes.
2016 Prostate Cancer Conference
July 1st 2016"The Prostate Cancer Research Institute, (PCRI), a 501(c)(3) not-for-profit organization, mission is to improve the quality of prostate cancer patients and caregivers lives by supporting research and disseminating information that educates and empowers patients, families and the medical community."
Niraparib Improves Outcomes for Patients With Ovarian Cancer
June 29th 2016Maintenance treatment with the novel agent niraparib improved progression-free survival (PFS) compared with placebo for patients with recurrent ovarian cancer harboring a germline BRCA (gBRCA) mutation or homologous recombination deficiency (HRD).